Our name, Cordator Life Science, is derived from the Latin words cor, heart, and cordatus, prudent, wise, judicious.
Working with integrity, knowledge and strategic vision (Cordatus) for the benefit of our clients (Cor).
Erik Lund
MSc Royal Institute of Technology, Stockholm; PhD Karolinska Institute, Stockholm
Erik is a co-founder of Cordator Life Science. He has >15 years of international large pharmaceutical company experience from Merck & Co and its subsidiary MSD (Merck Sharpe & Dohme) in research and business in the US and Europe. Within licensing and business development Erik has particular experience in search & evaluation, and deals concluded under Erik’s scientific responsibility range from early stage discovery collaboration to Phase III clinical stage projects. Erik has a large network in the industry, both in Europe and in US.
Prior to his career at Merck/MSD, Erik spent 4 years as a researcher at UT Southwestern Medical Center at Dallas in the department of Molecular Genetics, led by Nobel Prize Laureates Michael Brown and Joseph Goldstein.
erik.lund@cordator.com
+46-709-608853
Lars Öhman
MBA Stockholm School of Economics, Chemical Engineering, MSc Royal Institue of Technology Stockholm
Lars has a proven track record in drug discovery and business development within the pharmaceutical industry with over 25 years wide-ranging research and business experience in senior positions at Karo Bio AB following several years at Pharmacia.
He was responsible for in- and out-licensing of drug discovery and development projects to the pharmaceutical industry at Karo Bio from 2004 to 2012. He has led business transactions from lead identification to contract negotiations and has concluded deals with a potential value of several hundred million $.
Lars is very well connected in the US, Europe, Japan, Korea and India at all levels in the industry including large pharma, biotech, and academic groups.
lars.ohman@cordator.com
+46-70-8202686